Oncology

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Dopamine receptor blockers found to inhibit pancreatic tumor growth.

Mice treated with drugs that block a dopamine receptor inhibited cancer growth.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

New findings demonstrating differing mechanisms may contribute to a better understanding of acquired resistance to combination drug treatment in cancer.

High body mass index linked to 10 types of cancer, including cancers of the breast, bowel, esophageal, and womb.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Chemotherapy alone leaves behind dormant cells, but when combined with immunotherapy, it can destroy most of the dormant cells.

HIF-2 inhibitors may be better tolerated and more effective in kidney cancer.

Bristol-Myers Squibb employees will cycle across the US to raise awareness for cancer research.

Inhibiting immune cells’ oxygen-sensing capability prevented lung metastasis in mice.

The median charge of treatment for a 6-day hospital stay totals $37,000 in young cancer patients in need of stem cell transplants.

Chromosomal instability may be a potential biomarker for cancer prognosis.

The revolutionary CRISPR/Cas9 gene editing tool can target and inactivate cancer mutations, leading to more personalized therapies for patients.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Pembrolizumab (Keytruda) was previously granted Breakthrough Therapy Designation for advanced non-small cell lung cancer.

A Supplemental Biologics License Application was submitted for Keytruda for the treatment of lung cancer.

Top news of the day from across the health care landscape.

Preventative strategies necessary to reduce hospital admissions resulting from cancer treatments, medical complications, accidents, and self-harm.

Selective manipulation of an enzyme can stop cancer cachexia.

Vitamin A metabolite in the gut kills off cancer cells.

Immunotherapy able to kill triple-negative breast cancer cells via two-pronged strategy.

Higher levels of transport genes are an indicator of patients likely to be resistant to therapy with tamoxifen.

Top news of the week in oncology, and cancer drug development.

Experimental drug shows promise killing triple negative breast cancer cells.

Hepatitis C causes inflexible scar tissue to form in the liver.